Photodynamic therapy enhancement of anti-tumor immunity
- PMID: 21253659
- PMCID: PMC3197776
- DOI: 10.1039/c0pp00354a
Photodynamic therapy enhancement of anti-tumor immunity
Abstract
Photodynamic therapy (PDT) is an FDA-approved modality for the treatment of early-stage disease and palliation of late-stage disease. Pre-clinical studies using mouse models and clinical studies in patients have demonstrated that PDT is capable of influencing the immune system. The effect of PDT on the generation of anti-tumor immunity is regimen-dependent and is tightly linked to the degree and nature of inflammation induced by PDT. However, the precise mechanism underlying PDT-regulated adaptive anti-tumor immunity remains unclear. This review will focus on the current knowledge of immune regulation by PDT.
Figures
Similar articles
-
Enhancement of anti-tumor immunity by photodynamic therapy.Immunol Res. 2010 Mar;46(1-3):216-26. doi: 10.1007/s12026-009-8119-4. Immunol Res. 2010. PMID: 19763892 Free PMC article. Review.
-
PDT-induced inflammatory and host responses.Photochem Photobiol Sci. 2011 May;10(5):653-63. doi: 10.1039/c0pp00308e. Epub 2011 Jan 24. Photochem Photobiol Sci. 2011. PMID: 21258727
-
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.Cell Mol Immunol. 2017 Feb;14(2):223-234. doi: 10.1038/cmi.2015.84. Epub 2015 Sep 21. Cell Mol Immunol. 2017. PMID: 26388236 Free PMC article.
-
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.Br J Cancer. 2007 Jun 18;96(12):1839-48. doi: 10.1038/sj.bjc.6603792. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505510 Free PMC article.
-
Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).Photochem Photobiol Sci. 2011 May;10(5):681-8. doi: 10.1039/c0pp00315h. Epub 2011 Jan 24. Photochem Photobiol Sci. 2011. PMID: 21258718 Review.
Cited by
-
Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.Front Immunol. 2018 Nov 12;9:2478. doi: 10.3389/fimmu.2018.02478. eCollection 2018. Front Immunol. 2018. PMID: 30483247 Free PMC article. Review.
-
Photodynamic therapy and antitumor immunity.J Natl Compr Canc Netw. 2012 Oct 1;10 Suppl 2(0 2):S40-3. doi: 10.6004/jnccn.2012.0173. J Natl Compr Canc Netw. 2012. PMID: 23055214 Free PMC article.
-
Quantitative assessment of changes in cellular morphology at photodynamic treatment in vitro by means of digital holographic microscopy.Biomed Opt Express. 2019 Sep 6;10(10):4975-4986. doi: 10.1364/BOE.10.004975. eCollection 2019 Oct 1. Biomed Opt Express. 2019. PMID: 31646023 Free PMC article.
-
Photodynamic therapy mediated immune therapy of brain tumors.Neuroimmunol Neuroinflamm. 2018;5:27. doi: 10.20517/2347-8659.2018.31. Epub 2018 Jul 10. Neuroimmunol Neuroinflamm. 2018. PMID: 30221185 Free PMC article.
-
Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy.J Pharm Investig. 2018;48(2):143-151. doi: 10.1007/s40005-017-0377-x. Epub 2018 Nov 1. J Pharm Investig. 2018. PMID: 30680248 Free PMC article. Review.
References
-
- Korbelik M, Krosl G, Krosl J, Dougherty GJ. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 1996;56:5647–5652. - PubMed
-
- Korbelik M, Cecic I. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. 1999;137:91–98. - PubMed
-
- Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, Burg G, Binswanger U, Kempf W. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation. 2004;77:115–121. - PubMed
-
- Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61:192–196. - PubMed
-
- Maeurer MJ, Gollin SM, Storkus WJ, Swaney W, Karbach J, Martin D, Castelli C, Salter R, Knuth A, Lotze MT. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin. Cancer Res. 1996;2:641–652. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources